1. Home
  2. RCMT vs FATE Comparison

RCMT vs FATE Comparison

Compare RCMT & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RCM Technologies Inc.

RCMT

RCM Technologies Inc.

HOLD

Current Price

$27.50

Market Cap

140.8M

ML Signal

HOLD

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$1.19

Market Cap

125.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCMT
FATE
Founded
1971
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
140.8M
125.6M
IPO Year
1997
2013

Fundamental Metrics

Financial Performance
Metric
RCMT
FATE
Price
$27.50
$1.19
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$4.10
AVG Volume (30 Days)
60.1K
1.3M
Earning Date
04-03-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
27.38
29.88
EPS
2.14
N/A
Revenue
$186,737,000.00
$6,646,000.00
Revenue This Year
$16.29
N/A
Revenue Next Year
$6.92
N/A
P/E Ratio
$12.73
N/A
Revenue Growth
5.83
N/A
52 Week Low
$15.29
$0.86
52 Week High
$28.19
$1.94

Technical Indicators

Market Signals
Indicator
RCMT
FATE
Relative Strength Index (RSI) 82.25 47.67
Support Level $26.23 $1.06
Resistance Level N/A $1.30
Average True Range (ATR) 1.34 0.08
MACD 0.98 0.00
Stochastic Oscillator 96.68 53.70

Price Performance

Historical Comparison
RCMT
FATE

About RCMT RCM Technologies Inc.

RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: